Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): February 25, 2016

 

 

Acadia Healthcare Company, Inc.

(Exact Name of Registrant as Specified in Its Charter)

 

 

 

Delaware   001-35331   45-2492228

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

6100 Tower Circle, Suite 1000, Franklin, Tennessee 37067

(Address of Principal Executive Offices)

(615) 861-6000

(Registrant’s Telephone Number, including Area Code)

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (See General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 7.01. Regulation FD Disclosure.

Acadia Healthcare Company, Inc. (the “Company”) today filed its Annual Report on Form 10-K for the year ended December 31, 2015 and is providing reconciliations of adjusted income from continuing operations attributable to the Company to its audited statement of income for the year ended December 31, 2015. The updated reconciliations reflect a $7.0 million increase in the provision for income taxes compared to that reported in the Company’s earnings release issued February 16, 2016. This is due to an acquisition-related tax benefit that the Company determined could not be recognized until a future period. This change did not have an impact on the Company’s adjusted consolidated tax rate of 29.0% or its adjusted income from continuing operations attributable to the Company, adjusted EBITDA or net cash provided by continuing operating activities for the three months or year ended December 31, 2015. The reconciliations of non-GAAP financial measures are attached as Exhibit 99 hereto and are incorporated herein by reference.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit
Number

  

Description

99    Reconciliations of Non-GAAP Financial Measures


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    ACADIA HEALTHCARE COMPANY, INC.
Date: February 25, 2016     By:  

/s/ Christopher L. Howard

      Christopher L. Howard
      Executive Vice President, General Counsel and Secretary


EXHIBIT INDEX

 

Exhibit
Number

  

Description

99    Reconciliations of Non-GAAP Financial Measures